Minding the most critical of the senses
Beyond dry eye relief
Many of today’s consumers suffer from eye issues other than — or in addition to — dry eyes. For example, approximately a third of contact wearers experience contact lens dryness, according to a 2019 study from Princeton, N.J.-based Multi-sponsor Surveys Inc.
Bausch + Lomb Corp., Laval, Quebec, had these consumers in mind when it introduced its Biotrue Hydration Plus multipurpose solution. Formulated with “bio-inspired” ingredients, the solution keeps more moisture on contact lenses “so consumers can enjoy their lenses with all-day comfort,” said Joe Gordon, president, Global Consumer, Surgical and Vision Care.
Another eye-care issue? Almost half of Americans—42%—have insufficient levels of vitamin D, a recent HealthMatch article states. Vitamin D is proven to support healthy cell function and is critical for protecting eye health, Gordon noted.
“Additionally, daily stressors, including smart phones, sunlight and screens, can impact the eyes,” he pointed out. “And as people age, the natural filter—macula—in the eyes may weaken and leave the eyes more vulnerable to stress.”
To help here, Bausch + Lomb offers enhanced Ocuvite Adult 50+ eye vitamins with vitamin D. The vitamins’ key nutrients help protect eye health, particularly as consumers age, Gordon noted.
And the company has more innovation in the works, he said. This year will bring line extensions to the Biotrue brand, including Biotrue Hydration Boost contact lens rehydrating drops, and the company’s eye-health vitamins lineup.
“The company will also launch Lumify Eye Illuminations, a new line of specialty products designed for the sensitive eye area,” Gordon added.
- Growing demand for dry eye relief
An increasing number of consumers are seeking relief from dry eye syndrome. Also known as keratoconjunctivitis sicca (KCS) or dry eye disease, the syndrome is a condition in which the surface of the eyes lacks lubrication or moisture, Verified Market Research noted.
In its 2023 "Dry Eye Syndrome Market" report, the Jersey City, N.J.-based market research firm stated that the global market for dry eye relief products was valued at $5.53 billion in 2021 and is projected to reach $8.22 billion by 2030. That reflects a compound annual growth rate of 4.5% from 2023 to 2030.
“Aching and burning sensations, red eyes, sore eyes, itchy eyes, tired eyes, photophobia and other symptoms are all signs of dry eye,” Verified Market Research said. “Additionally, watery eyes may be a symptom because the dryness of the eye's surface overstimulates the creation of the watery component of tears. Excessive computer use, allergies, aging, LASIK eye surgery, menopause, hormone replacement treatment, smoking and other conditions can all contribute to dry eye syndrome.”
Dry eye disease is now considered to be a “critical and significant public health issue,” noted Susan Hanson, chief operating officer of The Relief Products, Reno, Nev. And up to half of American adults experience dry eye symptoms, she added, citing “Understanding Prevalence, Demographics of Dry Eye Disease,” a 2019 Ophthalmology Times article.
Verified Market Research anticipates that future growth in the dry eye product market will be driven by the rising geriatric and diabetes populations globally.
- New rule is music to many consumers’ ears
Close to 30 million adults in the United States could benefit from hearing-aid use, according to the U.S. Food and Drug Administration . However, hearing aids traditionally required a prescription—and came with a price tag too high for many consumers.
But on Aug. 16, 2022, the FDA issued a final rule establishing a new category of over-the-counter hearing aids. The action, which went into effect on Oct. 10, 2022, allows consumers with a perceived mild-to-moderate hearing impairment to purchase hearing aids directly from stores or from online retailers without the need for a medical exam, prescription or a fitting adjustment by an audiologist, the agency noted.
The rule is expected to lower the cost of hearing aids. It’s also designed to ensure the safety and effectiveness of OTC hearing aids while fostering innovation and competition in the hearing-aid technology marketplace, FDA said. The OTC category established in the rule applies to certain air-conduction hearing aids intended for people 18 years of age and older.
“Hearing loss is a critical public health issue that affects the ability of millions of Americans to effectively communicate in their daily social interactions,” said FDA Commissioner Robert M. Calif., M.D. “Establishing this new regulatory category will allow people with perceived mild-to-moderate hearing loss to have convenient access to an array of safe, effective and affordable hearing aids from their neighborhood store or online.”
New options for hearing loss
Some of the newest ear care innovations are in the OTC hearing aid space.
“It has never been easier for customers to receive support for their hearing loss,” said Christian Gormsen, CEO of Eargo, San Jose, Calif.
Although Eargo continues to see the introduction of hearing aids resembling earbud-style headphones, it’s focusing on “practically invisible” options to meet the needs of consumers who want a “more discreet device,” Gormsen said. The company’s latest OTC innovation—the self-fitting Eargo 7, which features Sound Adjust+ technology to mimic how natural hearing adapts to changing environments—debuted in January 2023.
“It combines the high tech and high touch of high-end devices at a more affordable price point, without compromising quality or user experience,” he said. “Eargo 7 is designed for discretion, measuring the size of a thumbnail … virtually invisible when in the ear and easily removed with a transparent pull tab.”
Charlotte Schrøder, senior manager of business development, Lifestyle Hearing for Jabra/GN Group in Copenhagen, Denmark, notes that her company continues to see more classic consumer electronics players entering the OTC hearing aid space.
“With this, new form factors and new features drawing on traditional consumer electronics experiences will emerge,” she said. “Tele-audiology and software-based services are being used to differentiate products. We also continue to see more focus on the use of AI to provide better user experiences.”
For its part, Jabra/GN Group recently introduced the Jabra Enhance Plus to the OTC hearing aid market.
“At $799 a pair, this is 80% cheaper than the average price paid today for a pair of traditional hearing aids purchased in a clinic, greatly expanding accessibility,” Schrøder said. “It’s important to note, however, that OTC is not a replacement of hearing aids as we know them today. Our Jabra Enhance Plus device provides a solution for those looking to begin their hearing health journey.”
Since OTC hearing aids hit the market, Eargo has noticed a positive trend, Gormsen noted: more conversations around general hearing wellness.
“Despite this, some customers are having a difficult time navigating what OTC hearing aids are and where they can purchase them, which is why we offer education and support every step along their journey,” he said.
Gormsen also encourages drug stores to consider the customer experience when it comes to planning and merchandising the OTC hearing aid assortment.
“Ease of access to affordable and high-quality hearing aids and comfort should be the top priority,” he said. “Simply placing a product … on the shelf is not enough. If the drug store is offering OTC hearing aids in a self-service station, the entire experience needs to be well thought out and intuitive for customers to avoid confusion and frustration.